ACM Biosciences AG
www.acmbiosciences.comACM Biosciences AG was established in Basel, Switzerland in September 2020. It is dedicated to the development of infectious disease vaccines using it's proprietary ACM polymersome platform technology. Its current primary focus is to get a safe, effective and highly manufacturable COVID-19 vaccine through clinical trials.
Read more
ACM Biosciences AG was established in Basel, Switzerland in September 2020. It is dedicated to the development of infectious disease vaccines using it's proprietary ACM polymersome platform technology. Its current primary focus is to get a safe, effective and highly manufacturable COVID-19 vaccine through clinical trials.
Read more
Country
City (Headquarters)
Basel
Industry
Employees
11-50
Founded
2020
Social
Employees statistics
View all employeesPotential Decision Makers
CDO / CBO
Email ****** @****.comPhone (***) ****-****
Reach decision makers at ACM Biosciences AG
Free credits every month!
ACM Biosciences AG FAQ
Basel, Switzerland
Biotechnology Research
